インフルエンザワクチン 世界総市場規模
QYResearch調査チームの最新レポートである「2024～2030年グローバルインフルエンザワクチン市場レポート」によると、2024年から2030年の予測期間中のCAGRが5.5%で、2030年までにグローバルインフルエンザワクチン市場規模は127.5億米ドルに達すると予測されている。
According to the new market research report “Global Influenza Vaccine Market Report 2024-2030”, published by QYResearch, the global Influenza Vaccine market size is projected to reach USD 12.75 billion by 2030, at a CAGR of 5.5% during the forecast period.
Figure 1: インフルエンザワクチン 世界総市場規模
Figure 2: 世界の インフルエンザワクチン 市場におけるトップ11企業のランキングと市場シェア（2023年の調査データに基づく；最新のデータは、当社の最新調査データに基づいている）
QYResearchのトップ企業研究センターによると、インフルエンザワクチンの世界的な主要製造業者には、Sanofi、CSL、GSK、Hualan Bio、Viatris、KM Biologics、AstraZeneca、Changchun Institute of Biological、Jiangsu GDK、Sinovacなどが含まれている。2023年、世界のトップ5企業は売上の観点から約82.0%の市場シェアを持っていた。
According to QYResearch, the global key manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Hualan Bio, Viatris, KM Biologics, AstraZeneca, Changchun Institute of Biological, Jiangsu GDK, Sinovac, etc. In 2023, the global top five players had a share approximately 82.0% in terms of revenue.
The market for influenza vaccines is influenced by a variety of factors, including healthcare policies, technological advancements, public awareness, and epidemiological trends. Here are some key drivers shaping the influenza vaccine market:
1. Global Disease Burden and Pandemic Preparedness: The global burden of influenza, including seasonal outbreaks and the potential for pandemics, drives the demand for influenza vaccines. Heightened concerns about the impact of influenza on public health, combined with the need for pandemic preparedness, contribute to sustained market demand.
2. Evolving Epidemiology and Viral Strain Diversity: The constantly evolving nature of influenza viruses necessitates ongoing vaccine development to address new strains and variants. The emergence of new influenza strains and the possibility of a severe global outbreak reinforce the need for effective vaccines, driving continuous research and development efforts within the market.
3. Growing Awareness and Immunization Campaigns: Public health initiatives, education campaigns, and vaccination programs contribute to increased awareness about the importance of influenza vaccination, driving higher demand for vaccines. Efforts to promote vaccination as a preventive measure play a crucial role in expanding the market.
4. Aging Population and High-Risk Groups: The aging population, along with individuals with chronic illnesses and immunocompromised individuals, are at higher risk of severe complications from influenza. The growing elderly population and increased focus on protecting high-risk groups contribute to market growth, as vaccination becomes a critical preventive measure for these demographics.
5. Government Funding and Support: Government initiatives, funding for public health programs, and policies mandating or recommending influenza vaccination impact market dynamics. Supportive government regulations, subsidies, and mass immunization programs often drive vaccine uptake and market growth.
6. Technological Advancements and Vaccine Innovation: Advances in vaccine research, including the development of more effective and efficient production methods, novel vaccine platforms, and broader antigen coverage, drive innovation within the influenza vaccine market. Improvements in vaccine technologies and production processes contribute to market expansion.
7. Expanded Access to Healthcare Services: Increasing access to healthcare services, particularly in emerging markets, can lead to higher vaccination rates and broader market reach for influenza vaccines. Improved healthcare infrastructure and access to vaccines in developing regions can significantly influence market growth.
8. Pandemic Events and Crisis Response: Major influenza outbreaks and pandemic events, such as the H1N1 influenza pandemic, can lead to heightened public awareness and investment in preparedness, including the stockpiling and distribution of influenza vaccines. These events often drive short-term market expansion and influence long-term strategies.
9. Rising Healthcare Expenditure and Insurance Coverage: Increasing healthcare expenditure and expanding insurance coverage for preventative healthcare services, including vaccination, contribute to market growth in influenza vaccines. Greater affordability and accessibility drive higher vaccination rates and market expansion.
10. Research and Development Incentives: Government funding, public-private partnerships, and incentives to stimulate research and development in vaccine technology support innovation within the influenza vaccine market, leading to the development of improved vaccines and novel formulations.
These drivers collectively shape the landscape of the influenza vaccine market, influencing vaccine development, distribution, and public health outcomes.
QYResearch会社概要
QYResearchは、2007年に設立され、本社はアメリカのロサンゼルスと中国の北京にある。17年以上にわたる持続的な成長の結果、QYResearchは、世界的に有名な、世界中の顧客に対してセグメント産業調査サービスを提供するリーディングなコンサルティング機関として成長した。ビジネスは世界160カ国以上に広がっており、30カ国以上に固定のマーケティングパートナーがあり、アメリカ、日本、韓国、インドなどに支店があり、国内の主要都市である北京、広州、長沙、石家庄、重慶、武漢、成都、山西大同、太原、昆明、日照などにはオフィスと専門的な研究チームが設置されている。
QYResearchは、高度技術産業の産業チェーンのさまざまな分野にわたる、世界的に有名な大手コンサルティング会社である。これらの分野には、半導体産業チェーン（半導体設備および部品、半導体材料、集積回路、製造、封装試験、ディスクリートデバイス、センサー、光電子デバイス）、太陽光発電産業チェーン（装置、シリコン素材／ウェーハー、セル、モジュール、補助材料、インバーター、発電所終端）、新エネルギー自動車産業チェーン（電力バッテリーおよび材料、電動ドライブ制御、自動車半導体／エレクトロニクス、車両、充電スタンド）、通信産業チェーン（通信システム装置、端末装置、電子部品、RFフロントエンド、光モジュール、4G/5G/6G、広帯域、IoT、デジタル経済、AI）、先進材料産業チェーン（金属材料、高分子材料、セラミックス材料、ナノ材料など）、機械製造産業チェーン（CNC機械、建設機械、電気機械、3Cオートメーション、産業用ロボット、レーザー、産業制御、無人航空機）、食品医薬品、医療機器、農業などが含まれる。